Report date: Apr 30, 2024
Conflict count: 350192
Publisher: TRC Colleges
Title count: 1
Conflict count: 1


==========================================================

Created: 2023-03-03 19:44:21.0
ConfID: 6749496
CauseID: 1563575657
OtherID: 1563575410
JT: Special journal of the Medical Academy and other Life Sciences
MD: Vasilieva, 1 ,3,null,2023,Intralipid blocks the entry of the SARS-Cov2/COVID/19 virus into cells by maintaining receptor a leucine-rich repeat containing 15 (LRRC15), an angiotensin-converting enzyme 2 receptor competitor.
DOI: 10.58676/sjmas.v1i1.15(Journal) (6749496-N )
DOI: 10.58676/sjmas.v1i3.15(Journal)